• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊拉克和阿富汗与战斗相关损伤所致感染的流行病学

Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan.

作者信息

Murray Clinton K

机构信息

Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

出版信息

J Trauma. 2008 Mar;64(3 Suppl):S232-8. doi: 10.1097/TA.0b013e318163c3f5.

DOI:10.1097/TA.0b013e318163c3f5
PMID:18316967
Abstract

Enhanced medical training of front line medical personnel, personal protective equipment, and the presence of far forward surgical assets have improved the survival of casualties in the current wars in Iraq and Afghanistan. As such, casualties are at higher risk of infectious complications of their injuries including sepsis, which was a noted killer of casualties in previous wars. During the current conflicts, military personnel who develop combat-related injuries are at substantial risk of developing infections with multidrug resistant bacteria. Herein, we describe the bacteriology of combat-related injuries in Operation Iraqi Freedom and Operation Enduring Freedom that develop infections with particular attention to injuries of the extremities, central nervous system, abdomen and thorax, head and neck, and burns. In addition, the likely sources of combat-related injuries with multidrug resistant bacteria infections are explored.

摘要

加强一线医务人员的医学培训、提供个人防护装备以及配备前沿外科资源,提高了伊拉克和阿富汗当前战争中伤员的生存率。因此,伤员因伤发生感染并发症(包括败血症)的风险更高,败血症在以往战争中是导致伤员死亡的一个显著因素。在当前冲突中,遭受与战斗相关损伤的军事人员感染多重耐药菌的风险很大。在此,我们描述了伊拉克自由行动和持久自由行动中发生感染的与战斗相关损伤的细菌学情况,特别关注四肢、中枢神经系统、腹部和胸部、头颈部以及烧伤的损伤情况。此外,还探讨了多重耐药菌感染的与战斗相关损伤的可能来源。

相似文献

1
Epidemiology of infections associated with combat-related injuries in Iraq and Afghanistan.伊拉克和阿富汗与战斗相关损伤所致感染的流行病学
J Trauma. 2008 Mar;64(3 Suppl):S232-8. doi: 10.1097/TA.0b013e318163c3f5.
2
Infectious disease complications of combat-related injuries.与战斗相关损伤的传染病并发症。
Crit Care Med. 2008 Jul;36(7 Suppl):S358-64. doi: 10.1097/CCM.0b013e31817e2ffc.
3
Combat wounds in operation Iraqi Freedom and operation Enduring Freedom.伊拉克自由行动和持久自由行动中的战斗创伤。
J Trauma. 2008 Feb;64(2):295-9. doi: 10.1097/TA.0b013e318163b875.
4
Infections in combat casualties during Operations Iraqi and Enduring Freedom.伊拉克行动和持久自由行动期间战斗伤员的感染情况。
J Trauma. 2009 Apr;66(4 Suppl):S138-44. doi: 10.1097/TA.0b013e31819d894c.
5
[Epidemiology of war injuries, about two conflicts: Iraq and Afghanistan].[战争创伤的流行病学,关于两场冲突:伊拉克和阿富汗]
Ann Fr Anesth Reanim. 2011 Nov;30(11):819-27. doi: 10.1016/j.annfar.2011.05.018. Epub 2011 Oct 5.
6
Incidence and epidemiology of combat injuries sustained during "the surge" portion of operation Iraqi Freedom by a U.S. Army brigade combat team.美国陆军一个旅级战斗队在伊拉克自由行动“增兵”阶段所遭受战斗损伤的发生率及流行病学情况。
J Trauma. 2010 Jan;68(1):204-10. doi: 10.1097/TA.0b013e3181bdcf95.
7
Characterization of extremity wounds in Operation Iraqi Freedom and Operation Enduring Freedom.伊拉克自由行动和持久自由行动中肢体创伤的特征描述
J Orthop Trauma. 2007 Apr;21(4):254-7. doi: 10.1097/BOT.0b013e31802f78fb.
8
Epidemiology of combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom: orthopaedic burden of disease.伊拉克自由行动和持久自由行动中战斗创伤的流行病学:骨科疾病负担
J Surg Orthop Adv. 2010 Spring;19(1):2-7.
9
Combat wounds in Iraq and Afghanistan from 2005 to 2009.2005 年至 2009 年在伊拉克和阿富汗的战斗伤口。
J Trauma Acute Care Surg. 2012 Jul;73(1):3-12. doi: 10.1097/TA.0b013e318250bfb4.
10
Resource utilization and disability outcome assessment of combat casualties from Operation Iraqi Freedom and Operation Enduring Freedom.伊拉克自由行动和持久自由行动中战斗伤员的资源利用及残疾结果评估。
J Orthop Trauma. 2009 Apr;23(4):261-6. doi: 10.1097/BOT.0b013e31819dfa04.

引用本文的文献

1
In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®.厄他培南、妥布霉素和莫西沙星对在玻璃珠或疾病控制与预防中心生物膜反应器中生长的生物膜的体外抗生物膜疗效。
PLoS One. 2025 Feb 10;20(2):e0318487. doi: 10.1371/journal.pone.0318487. eCollection 2025.
2
A Bead Biofilm Reactor for High-Throughput Growth and Translational Applications.用于高通量生长和转化应用的珠状生物膜反应器。
Microorganisms. 2024 Aug 5;12(8):1588. doi: 10.3390/microorganisms12081588.
3
Impact of the 4th of August Beirut explosion mass casualty incident on a university hospital microbial Flora.
8 月 4 日贝鲁特爆炸事件大量伤员对一家大学医院微生物群的影响。
BMC Infect Dis. 2024 Jan 4;24(1):48. doi: 10.1186/s12879-023-08818-4.
4
Department of Defense Trauma Registry Infectious Disease Module Impact on Clinical Practice.国防部创伤登记传染性疾病模块对临床实践的影响。
Mil Med. 2022 May 4;187(Suppl 2):7-16. doi: 10.1093/milmed/usac050.
5
Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.多药耐药和毒力生物体创伤感染:创伤感染性疾病结局研究倡议。
Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131.
6
efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by .一种独特的一流抗生物膜抗生素对由……引起的生物膜相关伤口感染的疗效。
Biofilm. 2020 Jul 17;2:100032. doi: 10.1016/j.bioflm.2020.100032. eCollection 2020 Dec.
7
After the Battlefield: Infectious Complications among Wounded Warriors in the Trauma Infectious Disease Outcomes Study.战场之后:创伤感染性疾病结局研究中受伤战士的感染并发症
Mil Med. 2019 Nov 1;184(Suppl 2):18-25. doi: 10.1093/milmed/usz027.
8
Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.抗菌肽RP557用于伤口病原体和生物膜广谱治疗的评估
Front Microbiol. 2019 Jul 24;10:1688. doi: 10.3389/fmicb.2019.01688. eCollection 2019.
9
Selenium nanoparticles as anti-infective implant coatings for trauma orthopedics against methicillin-resistant and : in vitro and in vivo assessment.载硒纳米颗粒抗感染植入物涂层治疗创伤骨科耐甲氧西林金黄色葡萄球菌感染:体外与体内评价。
Int J Nanomedicine. 2019 Jul 1;14:4613-4624. doi: 10.2147/IJN.S197737. eCollection 2019.
10
Combat-Related Extremity Wounds: Injury Factors Predicting Early Onset Infections.与战斗相关的四肢创伤:预测早期感染的损伤因素
Mil Med. 2019 Mar 1;184(Suppl 1):83-91. doi: 10.1093/milmed/usy336.